A woman with obstructive sleep apnea wakes repeatedly through the night, her breathing interrupted sometimes hundreds of times. Over time, that same woman may also find herself making urgent, frequent trips to the bathroom, often before she has even fully surfaced from sleep.
The connection between these two conditions, a breathing disorder that suffocates sleep and a bladder condition that hijacks it, has long been suspected but mostly studied in men. A new narrative review published July 21 in Current Urology Reports shifts the lens squarely to women, synthesizing evidence that sleep apnea may be a significant and treatable driver of overactive bladder in female patients.
The authors, physiatrist Elif Balevi Batur and urologist Ali Furkan Batur of Selcuk University in Turkey, argue that obstructive sleep apnea syndrome (OSAS) is not merely a respiratory disorder but a multisystem disease with direct effects on the lower urinary tract. Their review, which cites 39 studies, is the first to specifically catalog the mechanisms linking OSAS to overactive bladder (OAB) through a female lens.
Six threads, one knot
The review identifies six interconnected biological pathways that may explain how a disorder of the upper airway winds up affecting the bladder.
The first is intermittent hypoxia, the repeated drops in blood oxygen that characterize sleep apnea. Each apnea event starves tissues of oxygen, and the resulting cellular stress appears to sensitize the detrusor muscle of the bladder wall, making it more prone to involuntary contractions.
Second, the autonomic nervous system takes a beating. Sleep apnea triggers repeated surges of sympathetic activity as the brain fights to restart breathing. Over time this sympathetic overdrive can dysregulate the neural signals that normally keep the bladder at rest between voids, tipping the balance toward urgency and frequency.
Third, the heart’s atrial natriuretic peptide (ANP), a hormone that tells the kidneys to flush salt and water, is released in excess during the negative intrathoracic pressure swings of apnea. The result is nocturnal polyuria: the body produces more urine at night than it should, flooding the bladder while the patient is trying to sleep.
Fourth, circadian rhythm disruption compounds the problem. Sleep fragmentation desynchronizes the body’s internal clock, and the diurnal rhythm of bladder function collapses. Urine production and bladder capacity lose their normal day-night pattern.
Fifth and sixth, systemic inflammation and oxidative stress, both elevated in untreated sleep apnea, directly damage bladder tissue and the nerves that govern continence. Pro-inflammatory cytokines circulating at high levels can lower the threshold for detrusor activation, while reactive oxygen species degrade the urothelial barrier that protects the bladder lining.
The female factor
What makes the new review distinctive is its attention to sex-specific biology. Most prior work linking sleep apnea to bladder symptoms has focused on men, who are more likely to be diagnosed with OSAS in the first place, or on nocturia alone, nighttime urination, without examining the full OAB symptom complex of urgency, frequency, and urge incontinence.
In women, the review notes, three amplifying factors converge. Menopause and the accompanying estrogen deficiency thin and weaken the urethral and bladder tissues that depend on hormonal support for structural integrity. Pelvic floor dysfunction, more common in women due to pregnancy and childbirth, further compromises the support structures that help the bladder resist pressure from the abdomen during apnea events. And sleep apnea in women is frequently underdiagnosed, meaning the underlying driver of bladder symptoms may go untreated for years.
The authors emphasize that women with refractory OAB, symptoms that do not respond to standard treatments such as anticholinergic drugs or behavioral therapy, should be evaluated for sleep-disordered breathing, particularly if nocturia is a prominent complaint.
CPAP as a bladder treatment
The review examines a small but consistent body of clinical evidence showing that continuous positive airway pressure (CPAP) therapy, the first-line treatment for obstructive sleep apnea, is associated with improvements in OAB symptoms. Several studies reported reductions in nighttime urination frequency, decreases in urgency episodes, and improved quality-of-life scores on validated OAB questionnaires after CPAP initiation.
The mechanism is not simply that CPAP improves sleep and thereby reduces awareness of bladder signals. The physiological explanation runs deeper: CPAP eliminates the intermittent hypoxia that drives bladder sensitization, dampens the sympathetic nervous system surges, and normalizes ANP secretion, reducing nocturnal urine production. By treating the upstream driver, CPAP may relieve downstream bladder symptoms that overactive bladder medications alone cannot touch.
This finding has practical implications for clinical practice. A woman who presents with bothersome overactive bladder symptoms and also snores, wakes gasping, or has daytime fatigue may have a reversible cause for her urinary complaints, one that a sleep study, not a urology workup, will uncover.
What remains unknown
The authors are careful to state what the evidence does not yet show. A causal relationship between OSAS and OAB has not been definitively established. Most of the available studies are observational, cross-sectional, or small interventional trials. Randomized controlled trials that prospectively track OAB symptoms before and after CPAP treatment, stratified by sex, are lacking.
The mechanisms proposed in the review, while biologically plausible, remain largely inferential. Direct evidence that intermittent hypoxia causes detrusor overactivity in humans is sparse. The relative contribution of each pathway, hypoxia versus autonomic dysregulation versus inflammation, for instance, is unknown, and it is likely that multiple mechanisms act synergistically rather than independently.
The authors also call for prospective studies specifically designed for women. Nearly all of the foundational work on the physiology linking sleep apnea to the lower urinary tract has been conducted in male animals or male-predominant cohorts. Whether the same mechanisms operate at the same thresholds in women, with their different hormonal milieu, pelvic anatomy, and sleep architecture, remains an open question.
Bottom line
The narrative review by Batur and Batur adds weight to a growing recognition in sleep medicine and urology that these two specialties have more to say to each other than they currently do. For the millions of women who suffer from overactive bladder and have not found relief through standard treatments, the message is this: look up. The cause of your bladder trouble may not be in your pelvis at all. It may be in the airway, collapsing silently every night while you sleep.
Source
Batur EB, Batur AF. “Obstructive Sleep Apnea Syndrome and Overactive Bladder: Expanding the Perspective to Women, A Narrative Review.” Current Urology Reports, July 21, 2026, 27(1):32. DOI: 10.1007/s11934-026-01347-y. PMID: 42479276.